Register
Login:
Share:
Email Facebook Twitter


Ariana forecast 47% rise in Kiziltepe gold production


Angle Share Price (AGL)



Share Price Information for Angle (AGL)


Share Price: 47.00Bid: 46.00Ask: 48.00Change: 0.00 (0.00%)No Movement on Angle
Spread: 2.00Spread as %: 4.35%Open: 48.50High: 47.80Low: 47.00Yesterday’s Close: 47.00

Angle Plc Ord 10P

Angle is listed in the FTSE AIM All-Share
Angle is part of the Support sector






Share Price SpacerPrice
47.00
Share Price SpacerBid
46.00
Share Price SpacerAsk
48.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
117,281
Share Price SpacerOpen
48.50
Share Price SpacerHigh
47.80
Share Price SpacerLow
47.00
Share Price SpacerClose
47.00
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 117.09m £55.03m 5,000

52 Week High 80.00 52 Week High Date 15-JUN-2017
52 Week Low 32.25 52 Week Low Date 8-SEP-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
24 62,324 54,957 -5.396 -8.71 0.00 0.00


London South East Users info for Angle




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

20-Apr-18
17:06:34
47.00
2,500
 
46.00
48.00
1,175
Trade Type:
Ordinary

20-Apr-18
16:19:11
47.50
25,000
Buy* 
46.00
48.00
11.88k
Trade Type:
Ordinary

20-Apr-18
15:58:30
47.50
3,262
Buy* 
46.00
48.00
1,549
Trade Type:
Ordinary




View more Angle trades >>

Directors Deals for Angle (AGL)
Trade DateActionNotifierPriceCurrencyAmountHolding
26-Oct-16Buy
Trade Notifier Information for Angle
Andrew D Newland held the position of CEO at Angle at the time of this trade.
 Andrew D Newland
57GBX1,350,0007054686
30-Apr-16Notification of Holding
Trade Notifier Information for Angle
Ian F Griffiths held the position of Finance Director at Angle at the time of this trade.
 Ian F Griffiths
00559546
30-Apr-16Notification of Holding
Trade Notifier Information for Angle
Garth Selvey held the position of Chairman at Angle at the time of this trade.
 Garth Selvey
0020000
View more Angle directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Today 09:41MalachiRE: OMG THIS IS JUST A JOKE47.00No Opinion
Loskins
I think recruitment to the major Anderson breast trial is expected to be complete by end H1 2018, and they will be falling over themselves to present the data at the first opportunity. That study is pivotal to the success of AGL, I understood that, if all goes to plan, the FDA would give their blessing (or not) in H2 2108.
I accept your concerns re protectionism, but think it unlikely that the FDA will be influenced by anything other than the results in front of them. Not all… Read More
Fri 22:37loskinsRE: OMG THIS IS JUST A JOKE47.00No Opinion
Absolutely, Angle have a fantastic product and everything seems to be falling into place BUT....and this is a big but...they still do not have FDA approval...in fact....they will not register for approval unit the current trails are finished which may take them until the end of the year...FDA approval for pioneering trailblazing technology to diagnosing cancer...who's guess???...established UK company vs Developing US compatriots...Trump protectionism !!!
Fri 18:15Malachihttps://youtu.be/vgBeMMRWv-M47.00No Opinion
SeeingTom

I agree, this is obligatory viewing, even though AN is not a natural presenter!
Fri 14:41hicorydicorydocOMG THIS IS JUST A JOKE47.00No Opinion
CAN WE ASK THE MARKET WHAT WOULD THEY LIKE
I AM NOW CONVINCED THAT THE MARKET DOES NOT LIKE Mr AN
Fri 14:29seeingtomOldie but a Goodie47.00No Opinion
https://youtu.be/vgBeMMRWv-M
Highly recommended for anyone with the vaguest interest in this stock. Even if you are knowledgeable about Angle already.
I'm an anorak so I love the technical detail, but even if you are not, I recommend sticking with the video all the way through.
Fri 09:31MalachiAGL48.50No Opinion
Although AGL has started on breast, I do not know any reason why the technique of cell separation based on physical characteristics, size, deformability, etc should not also apply to all solid tumours, including lymphoma, where the present approach is by needle biopsy under x ray control, or an open procedure.
Work is presently proceeding on patients with stage 3/4 malignancies, with near 100% CTC recovery rates. it will be very interesting to discover at what stage in a malignancy can be… Read More

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Angle (AGL) >>

Please login or register to post a message on Share Chat.





Angle Plc Ord 10P home pageWebsite: Angle Plc Ord 10P
Website Description: ANGLEplc.com



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.